429 related articles for article (PubMed ID: 18172499)
1. NUMB controls p53 tumour suppressor activity.
Colaluca IN; Tosoni D; Nuciforo P; Senic-Matuglia F; Galimberti V; Viale G; Pece S; Di Fiore PP
Nature; 2008 Jan; 451(7174):76-80. PubMed ID: 18172499
[TBL] [Abstract][Full Text] [Related]
2. Progress in the research of p53 tumour suppressor activity controlled by Numb in triple-negative breast cancer.
Xian J; Cheng Y; Qin X; Cao Y; Luo Y; Cao Y
J Cell Mol Med; 2020 Jul; 24(13):7451-7459. PubMed ID: 32501652
[TBL] [Abstract][Full Text] [Related]
3. A Numb-Mdm2 fuzzy complex reveals an isoform-specific involvement of Numb in breast cancer.
Colaluca IN; Basile A; Freiburger L; D'Uva V; Disalvatore D; Vecchi M; Confalonieri S; Tosoni D; Cecatiello V; Malabarba MG; Yang CJ; Kainosho M; Sattler M; Mapelli M; Pece S; Di Fiore PP
J Cell Biol; 2018 Feb; 217(2):745-762. PubMed ID: 29269425
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
5. Cooperation among Numb, MDM2 and p53 in the development and progression of pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Cell Tissue Res; 2013 Nov; 354(2):521-32. PubMed ID: 23881403
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activity.
Liu D; Cui L; Wang Y; Yang G; He J; Hao R; Fan C; Qu M; Liu Z; Wang M; Chen L; Li H; Guo D
Hepatology; 2016 Aug; 64(2):390-404. PubMed ID: 27106262
[TBL] [Abstract][Full Text] [Related]
7. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
8. MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism.
Sczaniecka M; Gladstone K; Pettersson S; McLaren L; Huart AS; Wallace M
J Biol Chem; 2012 Apr; 287(17):14052-68. PubMed ID: 22337874
[TBL] [Abstract][Full Text] [Related]
9. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal repression between P53 and TCTP.
Amson R; Pece S; Lespagnol A; Vyas R; Mazzarol G; Tosoni D; Colaluca I; Viale G; Rodrigues-Ferreira S; Wynendaele J; Chaloin O; Hoebeke J; Marine JC; Di Fiore PP; Telerman A
Nat Med; 2011 Dec; 18(1):91-9. PubMed ID: 22157679
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers.
Tosoni D; Pambianco S; Ekalle Soppo B; Zecchini S; Bertalot G; Pruneri G; Viale G; Di Fiore PP; Pece S
EMBO Mol Med; 2017 May; 9(5):655-671. PubMed ID: 28298340
[TBL] [Abstract][Full Text] [Related]
12. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.
Zhang J; Shao X; Sun H; Liu K; Ding Z; Chen J; Fang L; Su W; Hong Y; Li H; Li H
Oncotarget; 2016 Sep; 7(38):61036-61053. PubMed ID: 27506933
[TBL] [Abstract][Full Text] [Related]
13. A role for Numb in p53 stabilization.
Carter S; Vousden KH
Genome Biol; 2008; 9(5):221. PubMed ID: 18492217
[TBL] [Abstract][Full Text] [Related]
14. Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis.
Dhami GK; Liu H; Galka M; Voss C; Wei R; Muranko K; Kaneko T; Cregan SP; Li L; Li SS
Mol Cell; 2013 May; 50(4):565-76. PubMed ID: 23706821
[TBL] [Abstract][Full Text] [Related]
15. Plk1 phosphorylation of Numb leads to impaired DNA damage response.
Shao C; Chien SJ; Farah E; Li Z; Ahmad N; Liu X
Oncogene; 2018 Feb; 37(6):810-820. PubMed ID: 29059161
[TBL] [Abstract][Full Text] [Related]
16. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
17. Numblike and Numb differentially affect p53 and Sonic Hedgehog signaling.
Liu L; Lanner F; Lendahl U; Das D
Biochem Biophys Res Commun; 2011 Sep; 413(3):426-31. PubMed ID: 21893032
[TBL] [Abstract][Full Text] [Related]
18. Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway.
Pettersson S; Sczaniecka M; McLaren L; Russell F; Gladstone K; Hupp T; Wallace M
Biochem J; 2013 Mar; 450(3):523-36. PubMed ID: 23252402
[TBL] [Abstract][Full Text] [Related]
19. Exon 3 of the
Confalonieri S; Colaluca IN; Basile A; Pece S; Di Fiore PP
G3 (Bethesda); 2019 Oct; 9(10):3359-3367. PubMed ID: 31451549
[TBL] [Abstract][Full Text] [Related]
20. Serine/arginine protein-specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53.
Wang G; Sheng W; Shi X; Li X; Zhou J; Dong M
FEBS J; 2019 May; 286(9):1668-1682. PubMed ID: 30724469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
